Stock Taper
WALDW
WALDENCAST PLC
NASDAQ
$0.03
▲ UP 0.35% (0.00)

KEY STATISTICS

Market Cap$136.57 M
52w High$0.86
52w Low$0.02
Dividend Yield
Frequency
P/E-0.05
Volume3.84K
Shares Out.114.08M

COMPANY

LEADERSHIP

Felipe Dutra
CHIEF EXECUTIVE
Felipe Dutra

ABOUT

SECTOR
Consumer Defensive
WENT PUBLIC
May 19, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
367

PRICE

$0.03 ▲ UP 0.35% (+$0.00)
$0.02$0.02$0.03$0.0312:12 PM12:19 PM12:27 PM12:34 PM12:41 PM12:49 PM12:56 PM0.03

About Waldencast plc

http://www.waldencast.com ↗

Waldencast Acquisition Corp. offers advanced dermatologist- and professional-distributed skincare products, including Obagi and Obagi Clinical, to reduce signs of aging, damage, hyperpigmentation, and sun exposure.

INDUSTRY

Household & Personal Products

A PRODUCT WALDENCAST PLC IS KNOWN FOR

Obagi® saypha® MagIQ™
Obagi® saypha® MagIQ™

Waldencast's FDA-approved hyaluronic acid dermal filler, launched under the Obagi Medical brand, targets moderate to severe facial wrinkles, marking its entry into the U.S. medical aesthetics market.

Revenue by Products

IconPRODUCTQ4-2022
Product$90.39M
Royalty$1.99M

Revenue by Geography

MapREGIONQ4-2022
UNITED STATES$54.3M
CHINA$17M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow2
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Brousset Michel
Sale · 264.3K shares
2026-07-30
DIRECTOR, OFFICER: CHIEF GROWTH OFFICER
Sebti Hind
Sale · 193.8K shares
2026-07-30
OFFICER: CHIEF FINANCIAL OFFICER
Manfredi Manuel
Purchase · 79.3K shares
2026-07-30
OFFICER: CHIEF FINANCIAL OFFICER
Manfredi Manuel
Sale · 79.3K shares
2026-07-30

SECTORS PEERS

PEERPRICE
APCX$0.36COMPARE
BIYA$2.23COMPARE
AUUD$0.97COMPARE
OLB$0.31COMPARE
BOXL$5.95COMPARE
MASK$1.39COMPARE
MYSZ$2.60COMPARE